Literature DB >> 6185486

Mössbauer study of iron bleomycin and its activation intermediates.

R M Burger, T A Kent, S B Horwitz, E Münck, J Peisach.   

Abstract

Using Mössbauer spectroscopy, we have examined iron-bleomycin in various oxidation states and in complexes with dioxygen or carbon monoxide. Ferrous bleomycin is a high spin ferrous complex. Addition of O2 converts it into an EPR-silent oxygenated complex. Mössbauer studies in strong applied magnetic fields show that oxygenated bleomycin is diamagnetic. At 4.2 K, the quadrupole splitting delta EQ = -2.96 mm/s and the isomer shift delta = 0.16 mm/s suggest that its electronic structure is best described as low spin ferric iron bound to superoxide anion. A single electron reduction yields activated bleomycin, an EPR-active form that still retains oxygen and which is kinetically competent to initiate DNA cleavage. We have produced this complex by exposing ferrous bleomycin to O2 or by reacting ferric bleomycin with H2O2. The Mössbauer spectra give convincing evidence that the iron of activated bleomycin is low spin ferric. The decay of activated bleomycin yields low spin ferric bleomycin, a complex with Mössbauer parameters nearly identical with those reported for ferric cytochrome P-450. Although iron bleomycin does not have a polyaromatic structure like heme, many features of its electronic structure at the iron are very similar to those produced by the sulfur-coordinated heme iron of ferric cytochrome P-450, a protein that catalyzes a similar oxygen-dependent reaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Non-heme iron enzymes: contrasts to heme catalysis.

Authors:  Edward I Solomon; Andrea Decker; Nicolai Lehnert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

2.  Characterization of bleomycin-mediated cleavage of a hairpin DNA library.

Authors:  Zachary J Segerman; Basab Roy; Sidney M Hecht
Journal:  Biochemistry       Date:  2013-07-22       Impact factor: 3.162

3.  Nucleosomal histone protein protects DNA from iron-mediated damage.

Authors:  H U Enright; W J Miller; R P Hebbel
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

4.  Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods.

Authors:  Lei V Liu; Caleb B Bell; Shaun D Wong; Samuel A Wilson; Yeonju Kwak; Marina S Chow; Jiyong Zhao; Keith O Hodgson; Britt Hedman; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

5.  The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation.

Authors:  Anna Karawajczyk; Francesco Buda
Journal:  J Biol Inorg Chem       Date:  2004-12-01       Impact factor: 3.358

6.  Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sites.

Authors:  Edward I Solomon; Shaun D Wong; Lei V Liu; Andrea Decker; Marina S Chow
Journal:  Curr Opin Chem Biol       Date:  2009-03-09       Impact factor: 8.822

7.  Characterization of an Fe III-OOH species and its decomposition product in a bleomycin model system.

Authors:  Michael R Bukowski; Shourong Zhu; Kevin D Koehntop; William W Brennessel; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

Review 8.  The oxo/peroxo debate: a nonheme iron perspective.

Authors:  Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2004-08-05       Impact factor: 3.358

9.  Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae.

Authors:  S T Lim; C K Jue; C W Moore; P N Lipke
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

10.  Total syntheses of (-)-pyrimidoblamic acid and P-3A.

Authors:  Adam S Duerfeldt; Dale L Boger
Journal:  J Am Chem Soc       Date:  2014-01-21       Impact factor: 15.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.